{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:33:51Z","timestamp":1779266031088,"version":"3.51.4"},"reference-count":30,"publisher":"Tech Science Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.059426","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:58:36Z","timestamp":1743397116000},"page":"1485-1494","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the correlation and mechanism of natural killer cell cytotoxic sensitivity against gastric cancer"],"prefix":"10.32604","volume":"33","author":[{"given":"WENZHUO","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAODONG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHILAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHIYONG","family":"XIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUANYUAN","family":"JIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHAOYONG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","first-page":"2021 209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/cancers16172948","article-title":"Epidemiology of gastric cancer-changing trends and global disparities","volume":"16","author":"Inoue","year":"2024","journal-title":"Cancers"},{"key":"ref3","first-page":"100845","article-title":"Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review","volume":"41","author":"Mamun","year":"2024","journal-title":"Cancer Treat Res Commun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4508794","DOI":"10.1155\/2019\/4508794","article-title":"Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates","volume":"2019","author":"Sambi","year":"2019","journal-title":"J Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1039\/D0BM00036A","article-title":"Advances in living cell-based anticancer therapeutics","volume":"8","author":"Dong","year":"2020","journal-title":"Biomater Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4062\/biomolther.2021.180","article-title":"Strategies for manipulating T cells in cancer immunotherapy","volume":"30","author":"Lee","year":"2022","journal-title":"Biomol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11060-020-03450-7","article-title":"T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironmen","volume":"147","author":"Kwok","year":"2020","journal-title":"J Neurooncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"121997","DOI":"10.1016\/j.lfs.2023.121997","article-title":"Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer","volume":"330","author":"Elanany","year":"2023","journal-title":"Life Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.3390\/cancers14184439","article-title":"Cord blood-derived natural killer cell exploitation in immunotherapy protocols: more than a promise?","volume":"14","author":"Damele","year":"2022","journal-title":"Cancers"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1615\/CritRevImmunol.2024052486","article-title":"Current and future states of natural killer cell-based immunotherapy in hepatocellular carcinoma","volume":"44","author":"Nguyen","year":"2024","journal-title":"Crit Rev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0907650","article-title":"Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS","volume":"84","author":"Iannello","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12967-015-0632-8","article-title":"Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer","volume":"13","author":"Sakamoto","year":"2015","journal-title":"J Transl Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","article-title":"A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer","volume":"59","author":"Iliopoulou","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2020.01242","article-title":"Prognostic significance of tumor-infiltrating natural killer cells in solid tumors: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"103436","DOI":"10.1016\/j.drudis.2022.103436","article-title":"Breaking boundaries: current progress of anticancer NK cell-based drug development","volume":"28","author":"Wang","year":"2023","journal-title":"Drug Discov Today"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"584099","DOI":"10.3389\/fimmu.2020.584099","article-title":"Cord-blood natural killer cell-based immunotherapy for cancer","volume":"22","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.14348\/molcells.2021.0078","article-title":"iPSC-derived natural killer cells for cancer immunotherapy","volume":"44","author":"Karagiannis","year":"2021","journal-title":"Mol Cells"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jcyt.2022.12.003","article-title":"The NK-92 cell line-30 years later: its impact on natural killer cell research and treatment of cancer","volume":"25","author":"Klingemann","year":"2023","journal-title":"Cytotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14570","article-title":"Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2015.00093","article-title":"Cord blood as a source of natural killer cells","volume":"2","author":"Mehta","year":"2016","journal-title":"Front Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.21873\/anticanres.12891","article-title":"Immune therapeutics in the treatment of advanced gastric and esophageal cancer","volume":"38","author":"Park","year":"2018","journal-title":"Anticancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/JLB.5MR0920-198RR","article-title":"Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy","volume":"109","author":"Devillier","year":"2021","journal-title":"J Leukoc Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10147-020-01750-6","article-title":"Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis","volume":"25","author":"Hu","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/S0102-67202012000200011","article-title":"Correlation of natural killer cells with the prognosis of gastric adenocarcinoma","volume":"25","author":"Rosso","year":"2012","journal-title":"Arq Bras Cir Dig"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10120-012-0210-1","article-title":"Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients","volume":"16","author":"Saito","year":"2013","journal-title":"Gastric Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/ijc.22579","article-title":"Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells","volume":"120","author":"Jarahian","year":"2007","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1038\/s41598-019-45377-8","article-title":"CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse","volume":"9","author":"Taouk","year":"2019","journal-title":"Sci Rep"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-6\/OncolRes-33-06-59426\/OncolRes-33-59426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:34:36Z","timestamp":1763343276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n6\/61343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.059426","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}